Wells Fargo downgrades Boston Scientific (NYSE: BSX) from Outperform to Market Perform. Valuation range lowered to $9-$10 from $11-$12.

Wells ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE